National Institute of Neurological Disorders and Stroke, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA.
Toxins (Basel). 2012 Nov 20;4(11):1404-14. doi: 10.3390/toxins4111404.
The safety and efficacy of botulinum toxin for the treatment of focal hand and cranial dystonias are well-established. Studies of these adult-onset focal dystonias reveal both shared features, such as the dystonic phenotype of muscle hyperactivity and overflow muscle contraction and divergent features, such as task specificity in focal hand dystonia which is not a common feature of cranial dystonia. The physiologic effects of botulinum toxin in these 2 disorders also show both similarities and differences. This paper compares and contrasts the physiology of focal hand and cranial dystonias and of botulinum toxin in the management of these disorders.
肉毒毒素治疗局灶性手和颅部肌张力障碍的安全性和有效性已得到充分证实。这些成人发病的局灶性肌张力障碍的研究揭示了一些共同特征,如肌肉过度活动和肌肉溢出性收缩的肌张力障碍表型,以及一些不同特征,如局限性手肌张力障碍的任务特异性,这在颅部肌张力障碍中并不常见。这两种疾病中肉毒毒素的生理效应也表现出相似性和差异性。本文比较和对比了局限性手和颅部肌张力障碍的生理学以及肉毒毒素在这些疾病治疗中的作用。